Curesponse
1 known investors
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.
Founders & leadership
GN
Guy NeevCo-Founder & CEO
DR
Dr. Ravid StraussmanScientific Founder
DS
Dr. Seth SalpeterCo-Founder & CTO
ED
Eran DorCFO